Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 17.79
-0.42 (-2.31%)
Oct 23, 2026, 1:55 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 10.59 billion as of October 22, 2026. It is the 7,687th most valuable company in the world and the 1,478th biggest in China. Its market cap has decreased by 18.92% in one year.
Market Cap
10.59B
Enterprise Value
7.52B
Revenue
1.19B
Global Rank
Country Rank
#1,478 China
PE Ratio
53.37
ChartMarket Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 10.59B, a decrease of -62.36%. That is a compound annual growth rate of -18.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 10.59B | -4.51% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 13.12B |
| GemPharmatech | 11.37B |
| Nanjing Vazyme Biotech | 10.90B |
| Tibet Cheezheng Tibetan Medicine | 10.78B |
| Chengdu Olymvax Biopharmaceuticals | 10.62B |
| Shanghai Medicilon | 10.25B |
| Inner Mongolia Furui Medical Science | 10.16B |
| Chengzhi | 9.56B |